Cargando…
Risk Factors for Medication-Related Osteonecrosis of the Jaw—A Binomial Analysis of Data of Cancer Patients from Craiova and Constanta Treated with Zoledronic Acid
MRONJ (Medication-Related Osteonecrosis of the Jaw) is a condition observed in a subset of cancer patients who have undergone treatment with zoledronic acid in order to either prevent or treat bone metastases. The primary aim of this research was to establish the importance of risk factors in the de...
Autores principales: | , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10253558/ https://www.ncbi.nlm.nih.gov/pubmed/37297941 http://dx.doi.org/10.3390/jcm12113747 |
_version_ | 1785056434746032128 |
---|---|
author | Ciobanu, George Adrian Camen, Adrian Ionescu, Mihaela Vlad, Daniel Munteanu, Cristina Maria Gheorghiță, Mircea Ionuț Lungulescu, Cristian Virgil Staicu, Ionela Elisabeta Sin, Elena Claudia Chivu, Luminița Mercuț, Răzvan Popescu, Sanda Mihaela |
author_facet | Ciobanu, George Adrian Camen, Adrian Ionescu, Mihaela Vlad, Daniel Munteanu, Cristina Maria Gheorghiță, Mircea Ionuț Lungulescu, Cristian Virgil Staicu, Ionela Elisabeta Sin, Elena Claudia Chivu, Luminița Mercuț, Răzvan Popescu, Sanda Mihaela |
author_sort | Ciobanu, George Adrian |
collection | PubMed |
description | MRONJ (Medication-Related Osteonecrosis of the Jaw) is a condition observed in a subset of cancer patients who have undergone treatment with zoledronic acid in order to either prevent or treat bone metastases. The primary aim of this research was to establish the importance of risk factors in the development of medication-related osteonecrosis of the jaw in cancer patients receiving zoledronic acid therapy for bone metastases. The present study is an observational retrospective investigation conducted at two university centers, namely, Craiova and Constanța, and included cancer patients treated with zoledronic acid. The medical records of the patients were obtained over a four-year timeframe spanning from June 2018 to June 2022. The data analysis was carried out between January 2021 and October 2022. Patients were treated for cancer, bone metastases, and MRONJ according to the international guidelines. The research investigated a cohort of 174 cancer patients (109 females and 65 males) aged between 22 and 84 years (with a mean age 64.65 ± 10.72 years) seeking treatment at oncology clinics situated in Craiova and Constanța. The study conducted a binomial logistic regression to analyze ten predictor variables, namely, gender, age, smoking status, treatment duration, chemotherapy, radiotherapy, endocrine therapy, presence of diabetes mellitus (DM), obesity, and hypertension (HT). The results of the analysis revealed that only five of the ten predictor variables were statistically significant for MRONJ occurrence: duration of treatment (p < 0.005), chemotherapy (p = 0.007), and hypertension (p = 0.002) as risk factors, and endocrine therapy (p = 0.001) and obesity (p = 0.024) as protective factors. |
format | Online Article Text |
id | pubmed-10253558 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-102535582023-06-10 Risk Factors for Medication-Related Osteonecrosis of the Jaw—A Binomial Analysis of Data of Cancer Patients from Craiova and Constanta Treated with Zoledronic Acid Ciobanu, George Adrian Camen, Adrian Ionescu, Mihaela Vlad, Daniel Munteanu, Cristina Maria Gheorghiță, Mircea Ionuț Lungulescu, Cristian Virgil Staicu, Ionela Elisabeta Sin, Elena Claudia Chivu, Luminița Mercuț, Răzvan Popescu, Sanda Mihaela J Clin Med Article MRONJ (Medication-Related Osteonecrosis of the Jaw) is a condition observed in a subset of cancer patients who have undergone treatment with zoledronic acid in order to either prevent or treat bone metastases. The primary aim of this research was to establish the importance of risk factors in the development of medication-related osteonecrosis of the jaw in cancer patients receiving zoledronic acid therapy for bone metastases. The present study is an observational retrospective investigation conducted at two university centers, namely, Craiova and Constanța, and included cancer patients treated with zoledronic acid. The medical records of the patients were obtained over a four-year timeframe spanning from June 2018 to June 2022. The data analysis was carried out between January 2021 and October 2022. Patients were treated for cancer, bone metastases, and MRONJ according to the international guidelines. The research investigated a cohort of 174 cancer patients (109 females and 65 males) aged between 22 and 84 years (with a mean age 64.65 ± 10.72 years) seeking treatment at oncology clinics situated in Craiova and Constanța. The study conducted a binomial logistic regression to analyze ten predictor variables, namely, gender, age, smoking status, treatment duration, chemotherapy, radiotherapy, endocrine therapy, presence of diabetes mellitus (DM), obesity, and hypertension (HT). The results of the analysis revealed that only five of the ten predictor variables were statistically significant for MRONJ occurrence: duration of treatment (p < 0.005), chemotherapy (p = 0.007), and hypertension (p = 0.002) as risk factors, and endocrine therapy (p = 0.001) and obesity (p = 0.024) as protective factors. MDPI 2023-05-29 /pmc/articles/PMC10253558/ /pubmed/37297941 http://dx.doi.org/10.3390/jcm12113747 Text en © 2023 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Ciobanu, George Adrian Camen, Adrian Ionescu, Mihaela Vlad, Daniel Munteanu, Cristina Maria Gheorghiță, Mircea Ionuț Lungulescu, Cristian Virgil Staicu, Ionela Elisabeta Sin, Elena Claudia Chivu, Luminița Mercuț, Răzvan Popescu, Sanda Mihaela Risk Factors for Medication-Related Osteonecrosis of the Jaw—A Binomial Analysis of Data of Cancer Patients from Craiova and Constanta Treated with Zoledronic Acid |
title | Risk Factors for Medication-Related Osteonecrosis of the Jaw—A Binomial Analysis of Data of Cancer Patients from Craiova and Constanta Treated with Zoledronic Acid |
title_full | Risk Factors for Medication-Related Osteonecrosis of the Jaw—A Binomial Analysis of Data of Cancer Patients from Craiova and Constanta Treated with Zoledronic Acid |
title_fullStr | Risk Factors for Medication-Related Osteonecrosis of the Jaw—A Binomial Analysis of Data of Cancer Patients from Craiova and Constanta Treated with Zoledronic Acid |
title_full_unstemmed | Risk Factors for Medication-Related Osteonecrosis of the Jaw—A Binomial Analysis of Data of Cancer Patients from Craiova and Constanta Treated with Zoledronic Acid |
title_short | Risk Factors for Medication-Related Osteonecrosis of the Jaw—A Binomial Analysis of Data of Cancer Patients from Craiova and Constanta Treated with Zoledronic Acid |
title_sort | risk factors for medication-related osteonecrosis of the jaw—a binomial analysis of data of cancer patients from craiova and constanta treated with zoledronic acid |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10253558/ https://www.ncbi.nlm.nih.gov/pubmed/37297941 http://dx.doi.org/10.3390/jcm12113747 |
work_keys_str_mv | AT ciobanugeorgeadrian riskfactorsformedicationrelatedosteonecrosisofthejawabinomialanalysisofdataofcancerpatientsfromcraiovaandconstantatreatedwithzoledronicacid AT camenadrian riskfactorsformedicationrelatedosteonecrosisofthejawabinomialanalysisofdataofcancerpatientsfromcraiovaandconstantatreatedwithzoledronicacid AT ionescumihaela riskfactorsformedicationrelatedosteonecrosisofthejawabinomialanalysisofdataofcancerpatientsfromcraiovaandconstantatreatedwithzoledronicacid AT vladdaniel riskfactorsformedicationrelatedosteonecrosisofthejawabinomialanalysisofdataofcancerpatientsfromcraiovaandconstantatreatedwithzoledronicacid AT munteanucristinamaria riskfactorsformedicationrelatedosteonecrosisofthejawabinomialanalysisofdataofcancerpatientsfromcraiovaandconstantatreatedwithzoledronicacid AT gheorghitamirceaionut riskfactorsformedicationrelatedosteonecrosisofthejawabinomialanalysisofdataofcancerpatientsfromcraiovaandconstantatreatedwithzoledronicacid AT lungulescucristianvirgil riskfactorsformedicationrelatedosteonecrosisofthejawabinomialanalysisofdataofcancerpatientsfromcraiovaandconstantatreatedwithzoledronicacid AT staicuionelaelisabeta riskfactorsformedicationrelatedosteonecrosisofthejawabinomialanalysisofdataofcancerpatientsfromcraiovaandconstantatreatedwithzoledronicacid AT sinelenaclaudia riskfactorsformedicationrelatedosteonecrosisofthejawabinomialanalysisofdataofcancerpatientsfromcraiovaandconstantatreatedwithzoledronicacid AT chivuluminita riskfactorsformedicationrelatedosteonecrosisofthejawabinomialanalysisofdataofcancerpatientsfromcraiovaandconstantatreatedwithzoledronicacid AT mercutrazvan riskfactorsformedicationrelatedosteonecrosisofthejawabinomialanalysisofdataofcancerpatientsfromcraiovaandconstantatreatedwithzoledronicacid AT popescusandamihaela riskfactorsformedicationrelatedosteonecrosisofthejawabinomialanalysisofdataofcancerpatientsfromcraiovaandconstantatreatedwithzoledronicacid |